Skip to Content

Baillie Gifford US Discovery Instl BGUIX

Medalist Rating as of | See Baillie Gifford Investment Hub
  • NAV / 1-Day Return 4.98  /  −0.80 %
  • Total Assets 2.2 Mil
  • Adj. Expense Ratio
    0.820%
  • Expense Ratio 0.820%
  • Distribution Fee Level Below Average
  • Share Class Type Institutional
  • Category Small Growth
  • Investment Style Small Growth
  • Min. Initial Investment
  • Status Open
  • TTM Yield
  • Turnover 11%

USD | NAV as of Apr 25, 2024 | 1-Day Return as of Apr 25, 2024, 10:14 PM GMT+0

Morningstar’s Analysis BGUIX

Will BGUIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

The combination of an Average People Pillar rating and a Below Average Process Pillar rating limit Baillie Gifford US Discovery Instl to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BGUIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 39.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Axon Enterprise Inc

6.19 143,925
Industrials

AeroVironment Inc

5.33 124,004
Industrials

TransMedics Group Inc

4.17 97,009
Healthcare

Freshpet Inc

3.96 91,993
Consumer Defensive

JFrog Ltd Ordinary Shares

3.84 89,324
Technology

Sprout Social Inc Class A

3.61 83,833
Technology

LiveRamp Holdings Inc

3.40 79,040
Technology

Novanta Inc

3.34 77,598
Technology

Varonis Systems Inc

3.16 73,538
Technology

Twist Bioscience Corp

2.90 67,488
Healthcare